Lehr Martin A. (CIK 0001861989)

Latest company ownership

CNTX - Context Therapeutics Inc.

Role: CEO

Shares held

291,402

Last filed at

Mar 22, 2024

Confidence Score

52.1

2025Q4

Confidence Score History

2021Q4 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Jun 9, 2025	Jun 10, 2025	Context Therapeutics Inc.	CEO	Buy	95.0	+100,000	10.21%	✗	$70.1K
Feb 21, 2023	Feb 21, 2023	Context Therapeutics Inc.	CEO	Buy	67.5	+5,823	0.60%	✓	$4.9K
Feb 13, 2023	Feb 13, 2023	Context Therapeutics Inc.	CEO	Buy	67.5	+5,606	0.58%	✓	$4.9K
Feb 6, 2023	Feb 6, 2023	Context Therapeutics Inc.	CEO	Buy	67.5	+5,040	0.52%	✓	$4.9K
Jan 30, 2023	Jan 30, 2023	Context Therapeutics Inc.	CEO	Buy	67.5	+7,027	0.73%	✓	$4.9K
Jan 23, 2023	Jan 23, 2023	Context Therapeutics Inc.	CEO	Buy	67.5	+6,839	0.72%	✓	$4.9K
Jan 17, 2023	Jan 18, 2023	Context Therapeutics Inc.	CEO	Buy	67.5	+6,783	0.72%	✓	$5K
Dec 16, 2022	Dec 19, 2022	Context Therapeutics Inc.	CEO	Buy	78.8	+20,000	2.17%	✗	$14.8K
Aug 19, 2022	Aug 22, 2022	Context Therapeutics Inc.	CEO	Buy	78.8	+13,000	1.43%	✗	$24.1K
Dec 16, 2021	Dec 20, 2021	Context Therapeutics Inc.	CEO	Buy	78.8	+13,000	1.45%	✗	$41.8K
Oct 22, 2021	Dec 17, 2021	Context Therapeutics Inc.	CEO	Buy	82.5	+10,000	1.13%	✗	$50K
Oct 22, 2021	Oct 25, 2021	Context Therapeutics Inc.	CEO	Buy	95.0	+10,000	11.16%	✗	$50K